… trial to compare the relative vaccine effectiveness (rVE) of the … quadrivalent (four-strain) flu vaccine with the inactivated quadrivalent standard … -25 respiratory virus seasons.  Sanofi funded the study, and … in the first trial, Sanofi had a role but didn …

… Hudson, Chief Executive Officer of Sanofi, said, “This new, significant capital … could transform patient care globally. Sanofi Ventures’ expanded investment will not … . The company develops medicines and vaccines targeting immune system-related diseases …

… seniors and kids, creating combination vaccines, investing in innovative delivery … adoption of inactivated vaccines globally. The live attenuated vaccine segment is … . Influenza Vaccine Market Key Players List GlaxoSmithKline plc Sanofi AstraZeneca CSL …

… with Sanofi’s strategic focus on immunology, neurology, vaccines and … phases.  This initiative supports Sanofi’s future innovation pipeline … .  In July 2025, Sanofi agreed to acquire Vicebio, … expected to expand its vaccine development capabilities.  Sign up …

… health companies. The fund, Sanofi Ventures, has already backed several … . That hesitance has given Sanofi an “opportunity” to lead … package which could get Sanofi or other potential acquirers … rare diseases, neurology, and vaccines. But Hafler said it wouldn …

… With Wednesday’s infusion, Sanofi Ventures will now have … and vaccine spaces. In a prepared statement on Wednesday, Sanofi … Biotherapeutics. Also backed by Sanofi Ventures is rare disease … four quarters. Still, like Sanofi, several investors have continued …

… Sanofi's key areas of immunology, rare diseases, neurology, and vaccines … science in healthcare. About Sanofi Sanofi is an R&D … to invent medicines and vaccines that treat and protect … 90 72 | yun.li3@sanofi.com Sanofi forward looking statement This …

… fast track designation to SAR446268, Sanofi's one-time AAV … for enrolment in late 2025. Sanofi has already been granted orphan … approved treatments for DM1. Sanofi is an R&D … system to invent medicines and vaccines that treat and protect millions …

… treatments for DM1. About Sanofi Sanofi is an R&D … to invent medicines and vaccines that treat and protect … 72 | yun.li3@sanofi.com Sanofi forward-looking statements This … plans” and similar expressions. Although Sanofi’s management believes that the …

… barrier to administration of this vaccine,” said Cody Meissner, MD … ’s COMIRNATY (mRNA) vaccine was approved only for individuals … -mRNA Nuvaxovid (sold by Sanofi in the US) for … significant concerns about vaccine policy and about vaccine mandates.” Meissner, …